HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 173 filers reported holding HEALTH CATALYST INC in Q4 2020. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,920,378 | -17.8% | 1,177,903 | +1.5% | 0.42% | -4.7% |
| Q2 2023 | $14,502,813 | +24.9% | 1,160,225 | +16.6% | 0.45% | +26.3% |
| Q1 2023 | $11,609,748 | +34.9% | 994,837 | +22.9% | 0.35% | +34.2% |
| Q4 2022 | $8,604,826 | +36.8% | 809,485 | +24.9% | 0.26% | +28.3% |
| Q3 2022 | $6,289,000 | -23.3% | 648,299 | +14.6% | 0.20% | -26.8% |
| Q2 2022 | $8,198,000 | -43.8% | 565,798 | +1.4% | 0.28% | -22.7% |
| Q1 2022 | $14,578,000 | -13.1% | 557,899 | +31.7% | 0.36% | +4.9% |
| Q4 2021 | $16,778,000 | +84.9% | 423,472 | +133.4% | 0.34% | +100.6% |
| Q3 2021 | $9,073,000 | +8.7% | 181,414 | +20.6% | 0.17% | +10.3% |
| Q2 2021 | $8,350,000 | +55.6% | 150,426 | +31.1% | 0.16% | +36.8% |
| Q1 2021 | $5,368,000 | +11.9% | 114,777 | +4.1% | 0.11% | +5.6% |
| Q4 2020 | $4,797,000 | +52.6% | 110,204 | +28.3% | 0.11% | +0.9% |
| Q3 2020 | $3,143,000 | – | 85,879 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Daventry Group, LP | 1,574,175 | $15,930,651 | 10.16% |
| First Light Asset Management, LLC | 2,930,144 | $29,653,057 | 2.82% |
| Nepsis Inc. | 905,804 | $9,166,736 | 2.81% |
| Granahan Investment Management | 1,177,903 | $11,920,378 | 0.42% |
| Rhenman & Partners Asset Management AB | 320,000 | $3,238,400 | 0.35% |
| Bares Capital Management | 700,000 | $7,084,000 | 0.30% |
| PIER 88 INVESTMENT PARTNERS LLC | 101,470 | $1,026,876 | 0.26% |
| Counterpoint Mutual Funds LLC | 24,086 | $243,750 | 0.20% |
| Brendel Financial Advisors LLC | 11,831 | $120 | 0.18% |
| CVS HEALTH Corp | 32,273 | $326,598 | 0.18% |